Showing 10,141 - 10,160 results of 50,373 for search '(( a ((linear decrease) OR (mean decrease)) ) OR ( a ((latest decrease) OR (larger decrease)) ))', query time: 1.15s Refine Results
  1. 10141
  2. 10142

    Effect of Systematic Follow-Up by General Practitioners after Deliberate Self-Poisoning: A Randomised Controlled Trial by Tine K. Grimholt (833045)

    Published 2015
    “…</p><p>Intervention</p><p>The GPs received a written guideline, contacted the patients and scheduled a consultation within one week after discharge, and then provided regular consultations for six months. …”
  3. 10143
  4. 10144
  5. 10145
  6. 10146
  7. 10147
  8. 10148
  9. 10149
  10. 10150
  11. 10151
  12. 10152

    Impact of decreasing RNA input amounts on overall probe sets detected at varying transcript abundances by the WT-Ovation FFPE and WT-Ovation One-Direct RNA amplification systems. by Laura Kennedy (18876)

    Published 2013
    “…<p>The number of probe sets detected at each signal intensity level (as a measure of transcript abundance) is shown. Numbers are the mean of duplicate arrays for input of 500 pg and below. …”
  13. 10153

    The effect of decreasing temperature at 2°C day<sup>−1</sup> on oxygen consumption (MO<sub>2</sub>) of young-of-the-year (YOY), small and adult (large) cunner. by Nick I. Kelly (675388)

    Published 2014
    “…The arrows indicate the temperature at which a rapid decrease in MO<sub>2</sub> was initiated for each size class. …”
  14. 10154

    Polyvinylalcohol-carbazate (PVAC) reduces red blood cell hemolysis by Felix Sellberg (8098511)

    Published 2019
    “…</p><p>Results</p><p>After test tube storage for two weeks, red blood cell hemolysis was lower with PVAC compared to controls (mean difference 23%, 95% CI 16–29%, p < 0.001). A higher level of hemolysis led to a pronounced effect with PVAC. …”
  15. 10155
  16. 10156
  17. 10157
  18. 10158
  19. 10159

    Decreased self-renewal capacity associated with senescence was prevented in human MSCs following treatment with Ki16425, an LPA<sub>1</sub>/LPA<sub>3</sub> antagonist. by Masahiko Kanehira (183764)

    Published 2012
    “…Fold-change represents decrease in band intensity of Ki16425 treatment for 18 days compared with a control treatment for the same period of time. …”
  20. 10160